C18 C19 C20
Conditions
Interventions
Group 1: Exercise group which passes an eight-week mixed endurance, strength and balance exercise program (twice a week, 60 minutes)
Group 2: waitlist control group which receives standard written rec
Sponsors
Medizinisches Versorgungszentrum Hämatologie Onkologie Essen gGmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - patients with metastasized colorectal cancer and estimated life expectancy of at least six months - written informed consent - hemoglobin = 9 g/dl
Exclusion criteria
Exclusion criteria: - WHO performance status > 2 - scheduled surgery during study period - contraindications for physical activity, particulary manifest heart failure (NYHA III-IV), symptomatic coronary heart disease, respiratory partial or global insufficiency, permanent thrombocytopenia <10.000/µl or platelet function disorders, severe hypertension refractory to treatment, uncontrollable cerebral seizure condition - concurrently participating in another exercise study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACT/GOG-NTX (version 4) questionnaire: Trial Outcome Index (consists of physical well-being, functional well-being and neuropathic symptoms); three investigations at baseline, after the intervention and four weeks after | — |
Secondary
| Measure | Time frame |
|---|---|
| endurance capacity (6-minute walk test), strength (hypothetic one repetition maximum), balance (GGT Reha) | — |
Countries
Germany
Contacts
Public ContactUrsula Timmers-Trebing
Verein für Gesundheitssport und Sporttherapie an der Universität Duisburg-Essen e.V.
Outcome results
None listed